Today, we are proud to announce the close of our $75 million Seed Round, our inaugural institutional fund, backed by BoxGroup and a select group of strategic limited partners who share our conviction that the next generation of iconic consumer brands will be built from day one on direct relationships with customers.

After years of seed investing in consumer and health companies from individual check capacity, this fund formalizes what has always been our core belief: that the most durable brands are those built on trust, evidence, and genuine consumer insight rather than temporary paid acquisition arbitrage or channel dependency. We call this the root evidence thesis, and it shapes every decision we make.

Why Now, Why Consumer DTC and Health

The consumer DTC landscape has gone through a reckoning over the past several years. The era of cheap Facebook ads and frictionless customer acquisition has given way to a more demanding environment where unit economics, brand equity, and authentic customer relationships determine who survives and who thrives. For us, this environment represents not a threat but a clarifying moment.

Health brands occupy a particular position within the broader consumer DTC universe. As consumers take increasing ownership of their physical wellbeing, mental health, longevity, and daily performance, the market for evidence-based health products has grown from a niche category into a mainstream consumer expectation. We have watched this shift happen in real time, and we believe the companies built today in this space will define the category for the next decade.

The $75M Seed Round gives us the capital to back twenty to twenty-five companies at the seed stage, writing initial checks between $1.5M and $4M and reserving meaningful follow-on capacity for our breakout companies. We are not a spray-and-pray operation. Every company in our portfolio will receive genuine partnership: access to our operator network, our distribution relationships, and the full attention of the Root Evidence team.

The Role of BoxGroup as Our Anchor Partner

We are grateful and genuinely excited to have BoxGroup as our anchor limited partner. BoxGroup has an exceptional reputation in the venture ecosystem as an early-stage investor with a long track record of backing founders at the very earliest stages of company formation. Their commitment to Root Evidence Ventures reflects a shared belief in seed-stage conviction investing and a mutual respect for the founder relationships that both organizations have built over many years.

BoxGroup's network and experience in early-stage company building have already proven invaluable as we finalized our fund formation. Their institutional knowledge and their own history of backing breakout consumer and health companies made them an ideal partner as we launched Root Evidence Ventures as a formal entity. We look forward to the deals and the insights we will share in the years ahead.

The partnership with BoxGroup is not a passive financial arrangement. It is an intellectual and strategic alignment around a shared view of how seed-stage investing in consumer and health should work: with patience, with conviction, and with a genuine commitment to helping founders navigate the hardest early stages of building a company.

Our Investment Thesis in Practice

The root evidence thesis rests on three pillars. First, we believe that direct-to-consumer brands that build genuine customer insight databases from their earliest days create an enduring competitive moat that platform-dependent brands cannot replicate. When a brand knows why its best customers buy, when they buy, and what outcomes they achieve, that knowledge compounds over time into an asset that no advertising algorithm can replicate.

Second, we believe that health brands occupy a uniquely defensible position in the consumer market because they operate at the intersection of desire and necessity. The best health brands solve real problems for real people and then build a community of advocates who make paid acquisition increasingly irrelevant over time. We have seen this dynamic play out across supplement brands, wellness devices, mental health platforms, and functional food companies, and we expect to see it continue across new categories that have not yet emerged.

Third, we believe that founders who combine deep category expertise with an evidence-based approach to product development and customer acquisition are systematically undervalued at the seed stage. Most venture capital firms move upstream in company age as their fund sizes grow. We are deliberately staying early, where the signal-to-noise is hardest to read and where our pattern recognition creates the most value.

What We Look for in Founders

Root Evidence Ventures writes its first check at the seed stage. In most cases, that means we are evaluating founders before they have meaningful revenue, before they have a complete team, and sometimes before they have a finished product. This requires a different kind of evaluation framework than you would apply to a company with two years of growth data.

We are not looking for the polished pitch. We are looking for founders who have an almost unreasonable level of curiosity about their target customer, who have already done primary research that most investors have never thought to ask for, and who can articulate why their approach to solving a customer problem is better than anything else in the market with specificity rather than generality.

We are looking for founders who understand their category's unit economics before they are relevant and who have a specific, time-bound roadmap to getting to a customer acquisition cost and lifetime value ratio that justifies the venture scale ambition they are asking us to share. We are looking for founders who have thought carefully about the brand identity they are building, not just the product, because in consumer DTC the brand often outlasts the initial product and needs to be built deliberately from day one.

We are also looking for founders who understand that the best outcomes in consumer and health are almost always multi-year, multi-product stories and who have the temperament to build through difficulty without losing the curiosity and experimental energy that made them interesting in the first place. Great consumer brands take time. We are prepared to be patient partners.

Portfolio Construction and What Comes Next

With the $75M Seed Round closed, we are now actively deploying capital across consumer DTC and health categories. Our initial focus areas include functional nutrition and supplements, personal care and skin health, mental wellness and sleep, fitness and performance, and health data platforms that serve the direct-to-consumer ecosystem. We are deliberately curious about categories that are emerging rather than established, because those are the spaces where evidence-based founders can define the terms of competition before incumbents arrive.

Over the next eighteen months, we expect to complete the initial portfolio of twenty to twenty-five companies that represents the core of this fund. Each company will receive a first check that signals genuine conviction, not just a toe in the water, and each founder will have direct access to the Root Evidence team for ongoing strategic support.

We will also be building out our operator advisory network over the coming months, adding experienced consumer and health executives who have built brands at scale and who can provide the kind of operational guidance that goes beyond what any venture investor can provide from an investment lens alone. If you are a former DTC operator or health brand builder who is interested in being part of the Root Evidence network, we would love to hear from you.

Key Takeaways

  • Root Evidence Ventures has closed a $75M Seed Round in April 2022, backed by BoxGroup.
  • The fund focuses exclusively on consumer DTC and health brands at the seed stage.
  • Initial check sizes range from $1.5M to $4M with follow-on reserves for breakout companies.
  • The portfolio will consist of 20 to 25 companies built on direct customer relationships and evidence-based product development.
  • BoxGroup serves as anchor limited partner, reflecting a shared conviction in early-stage consumer and health investing.

Conclusion

The close of our $75M Seed Round marks the beginning of a chapter we have been building toward for years. It formalizes our commitment to founder-first seed investing in consumer DTC and health, gives us the resources to build genuine partnerships with the companies we back, and establishes Root Evidence Ventures as a dedicated institutional presence in a market that we believe is still dramatically underserved at the earliest stages.

We are grateful to BoxGroup for their confidence in our thesis and our team. We are grateful to every founder who shared their vision with us during the fundraising process, whether or not we were the right partner for their specific journey. And we are genuinely excited about the companies we will build together over the years ahead.

If you are a founder working in consumer DTC or health who believes in the root evidence thesis, we would love to talk. You can reach us through our contact page, and we promise that every founder inquiry receives a thoughtful, timely response. Building great companies starts with the right conversations, and we are here for them.